Fibrinolytic components of human uterine arterial and venous blood

A V Mackay, Mackay AV, Das PC, P C Das, P R Myerscough, Myerscough PR, J D Cash, Cash JD
Journal of clinical pathology · 1967 · vol. 20(3) , pp. 227–30 · doi:10.1136/jcp.20.3.227 · PMID:5602553 · PMC473473
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-31 ⓘ

This study analyzed fibrinolytic components in uterine arterial and venous blood from 14 patients, finding significantly higher plasminogen activator and fibrin degradation product concentrations in the venous samples.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The fibrinolytic components of uterine arterial and venous blood were studied in 14 patients undergoing various obstetrical and gynaecological procedures. There was a highly significant higher concentration of plasminogen activator, as measured by the euglobulin lysis time, and fibrin degradation products in the uterine venous blood.

My notes (saved in your browser only)

MeSH descriptors

Fibrinolytic Agents Uterus Adult Arteries Blood Coagulation Tests Female Fibrin Fibrin Fibrinogen Fibrinogen Fibrinolysis Fibrinolytic Agents Genital Diseases, Female Genital Diseases, Female Hemagglutination Inhibition Tests Humans Middle Aged Models, Biological Plasminogen Plasminogen

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:57:48.939683+00:00
unpaywall
last seen: 2026-10-23T06:24:35.503409+00:00